Study of the QOL Evaluation of Trelagliptin in Patients With Type 2 Diabetes Mellitus
Clinical trial NCT03014479 · COMPLETED
Trial details
- NCT number
- NCT03014479
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-18
- Primary completion
- 2017-10-21
- Enrollment
- 219
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.